Psychodynamic aspects of some cardiac diseases: a cardiologist’s opinion

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The review considers the psychodynamic aspects of the most common diseases of the cardiovascular system. It analyzes the interrelation of biological, psychological, and social prerequisites during the manifestation of these nosology entities. Particular attention is paid to the dynamic relationship between psychogenesis and somatogenesis within the framework of a psychosomatic continuum of the disease.

全文:

受限制的访问

作者简介

A. Eremeev

Prof. O.V. Vladimirtsev Territorial Clinical Hospital

编辑信件的主要联系方式.
Email: shuryatik@mail.ru

Candidate of Medical Sciences

俄罗斯联邦, Khabarovsk

参考

  1. Velikanova L.P. Dynamic ratios of neurosis and psychosomatic disorders (Part 2). Social and clinical psychiatry. 2006; 1: 95–100 (in Russ.).
  2. Arndt P., Klingen N. Psychosomatics and Psychotherapy. M.: Medpress-inform, 2014; 365 p. (in Russ.).
  3. Galli F., Borghi L., Carugo S. et al. Atrial fibrillation and psychological factors: a systematic review. Peer J. 2017; 5 (1): e3537. doi: 10.7717/peerj.3537
  4. Psychosomatic disorders in clinical practice. Ed. А.В. Smulevich. 2nd ed. M.: MEDPress-inform, 2019; 774 p. (in Russ.).
  5. Friedman M., Rosenman R.H. Association of Specific Overt Behaviour Pattern with Blood and Cardiovascular Findings. JAMA. 1959; 169 (12): 1286–96. doi: 10.1001/jama.1959.03000290012005
  6. Denolle J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosomc Med. 2005; 67 (1): 89–97. doi: 10.1097/01.psy.0000149256.81953.49
  7. Šmigelskas K., Žemaitienė N., Julkunen J. et al. Type A behavior pattern is not a predictor of premature mortality. Int J Behav Med. 2015; 22: 161–9. doi: 10.1007/s12529-014-9435-1
  8. Lohse T., Rohrmann S., Richard A. et al. Type A personality and mortality: Competitiveness but not speed is associated with increased risk. Atherosclerosis. 2017; 262: 19–24. doi: 10.1016/j.atherosclerosis.2017.04.016
  9. Tabidze A.A. Theory and practice of genesis of psychogenic diseases. Psychotherapy. 2014; 11: 2–10 (in Russ.).
  10. Moons W.G., Shields G.S. Anxiety, Not Anger, Induces Inflammatory Activity: An Avoidance/ Approach Model of Immune System Activation. Emotion. 2015; 15 (4): 463–76. doi: 10.1037/emo0000055
  11. Parati G., Molinary E. Clinical psychology and heart disease. Milan: Springer, 2010; 510 p. doi: 10.1007/978-88-470-0378-1_4
  12. Horney H. The Neurotik Personality of Our Time. USA: WWW Norton&C, 1937; 300 p. doi: 10.1080/21674086.1937.11925336
  13. Kupper N., Denollet J. Type D Personality as a Risk Factor in Coronary Heart Disease: a Review of Current Evidence. Curr Cardiol Rep. 2018; 20 (11): 104. doi: 10.1007/s11886-018-1048-x
  14. Pushkarev G.S., Kuznetsov V.A., Yaroslavskaya E.I. et al. Clinical characteristics of patients with coronary heart disease with type Individuals D who underwent percutaneous coronary interventions. Cardiovascular therapy and prevention. 2015; 3: 25–9 (in Russ.). doi: 10.15829/1728-8800-2015-3-25-29
  15. Sumin A.N., Scheglova A.V. The concept of personality type D is a component in the formation of a personalized approach or a prognostic factor in the treatment of cardiovascular diseases? Russian Journal of Cardiology. 2020; 25 (9): 3996 (in Russ.). doi: 10.15829/1560-4071-2020-3996
  16. Zalesskaya Yu.V. Medical and social aspects of personality type D in the general population and in persons with coronary heart disease (review). Medical almanac. 2017; 1: 16–9 (in Russ.).
  17. Kang H.J., Bae K.Y., Kim S.W. et al. Relationship between interleukin-1 beta and depressive disorder after acute coronary syndrome. Prog Neuropsychopharmacol Biol Psychiatry. 2017; 72: 55–9. doi: 10.1016/j.pnpbp.2016.09.001
  18. Paleev N.R., Krasnov V.N. Relationship of Psychomatics and Somatopsychiatry in Modern Medicine. Clinical Medicine. 2009; 12: 4–7 (in Russ.).
  19. Kirilova N.A. Psychological well-being of an individual in old age depending on the type of aging. Research of young scientists: materials of the XV International. scientific. conf. (Kazan, December 2020). Kazan: Young scientist, 2020; рр. 102–4 (in Russ.). URL: https://moluch.ru/conf/stud/archive/384/16187/
  20. Bach M., Bach D. Alexithymia in somatoform disorder and somatic disease: a comparative study. Psychother Psychosom. 1996; 65 (3): 150–2. doi: 10.1159/000289067
  21. Grabe H.J., Schwahn C., Barnow S. Alexithymia, hypertension, and subclinical atherosclerosis in the general population. J Psychosom Res. 2010; 68: 139–47. doi: 10.1016/j.jpsychores.2009.07.015
  22. Zhuang Q., Wu L., Jie L. et al. Negative emotions in community-dwelling adults with prediabetes and hypertension. J Int Med Res. 2020; 48 (4): 30006052091841. doi: 10.1177/0300060520918411
  23. Sidorov P.I., Novikova I.A. Mental Medicine. M.: GEOTAR-Media, 2014; 725 p. (in Russ.).
  24. Syrkin A.L., Medvedev V.E., Kopylov F.Y. et al. Impact of pathocharacterological disorders on the course of hypertension. Vrach. 2007; 4: 10–2 (in Russ.).
  25. Schmieder R.E. End organ damage in hypertension. Dtsch Ärztebl Int. 2010; 107 (49): 866–73. doi: 10.3238/arztebl.2010.0866
  26. Oliva F., Versino E., Nicoletta L. et al. Type D Personality and Essential Hypertension in Primary Care: A Cross-Sectional Observational Study Within a Cohort of Patients Visiting General Practitioners. J Nerv Ment Dis. 2016; 204 (1): 43–8. doi: 10.1097/NMD.0000000000000421
  27. Wu E.-L., Chien I.C., Lin C.-H. Increased risk of hypertension in patients with anxiety disorders: A population-based study. J Psychosom Res. 2014; 72 (6): 522–7. doi: 10.1016/j.jpsychores.2014.10.006
  28. Akimova E.V., Gakova E.I., Kayumov R.H. Personal anxiety and cardiovascular diseases in the open population. Scientific Thought. 2015; (6): 66–75 (in Russ.)
  29. Golukhova E.Z., Zholbaeva A.Z., Arakelyan M.G. et al. Genetic aspects of lone atrial fibrillation in patients without structural heart disease. Annals of the Russian Academy of Medical Sciences. 2019; 74 (4): 245–52 (in Russ.). doi: 10.15690/vramn1120
  30. Troshina D.V., Volel' B.A., Syrkina E.A. Stress-induced atrial fibrillation. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019; 119 (1): 6–13 (in Russ.). doi: 10.17116/jnevro20191190116
  31. Thompson T.S., Barksdale D.J., Sears S.F. et al. The effect of anxiety and depression on symptoms attributed to atrial fibrillation. Pacing Clin Electrophysiol. 2014; 37 (4): 439–46. doi: 10.1111/pace.12292
  32. Dedov D.V., Ivanov A.P., Elgardt I.A. Risk of recurrent atrial fibrillation in patients with coronary heart disease and arterial hypertension according to Holter electrocardiogram monitoring. Vestnik aritmologii. 2010; 59: 27–32 (in Russ.).
  33. Dedov D.V., Ivanov A.P., Elgardt I.A. Electro-mechanical heart remodelling and atrial fibrillation development in patients with coronary heart disease and arterial hypertension. Russ J Cardiol. 2011; 16 (4): 13–8 (in Russ.).
  34. Dzeshka M.S., Lip G.Y., Snezhitskiy V. et al. Cardiac fibrosis in with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol. 2015; 66 (8): 943–59. doi: 10.1016/j.jacc.2015.06.1313
  35. Kuzmin V.S., Rosenstrauch L.V. Modern conceptions of the atrial fibrillation development. The role of the myocardial sleeves in the pulmonary veins. Usp Fiziol Nauk. 2010; 41 (4): 3–26 (in Russ.).
  36. Doisne N., Maupoil V., Cosnay P. et al. Catecholaminergic automatic activity in the rat pulmonary vein: electrophysiological differences between cardiac muscle in the left atrium and pulmonary vein. Am J Physiol Heart Circ Physiol. 2009; 297 (10): H102–108. doi: 10.1152/ajpheart.00256.2009
  37. Jug J., Čilić M., Benčić M.L. et al. Obesity and atrial fibrillation. Cardiologia Croatica. 2019; 14 (7-8): 174–9. doi: 10.15836/ccar2019.174
  38. Van Driel T.J.W., Hilderink P.H., Hanssen D.J.C. et al. Assessment of somatization and medically unexplained symptoms in later life. Assessment. 2018; 25: 374–93. doi: 10.1177/1073191117721740
  39. Mohapatr S., Satapathy A. Somatoform Disorders in Children and Adolescents. German J Psychiatry. 2014; 17 (1): 7–10.
  40. Volel B.A., Petelin D.S., Akhapkin R.V. et al. Cognitive impairment in anxiety disorders. Neurology, Neuropsychiatry, Psychosomatics. 2018; 10 (1): 78–82 (in Russ.). doi: 10.14412/2074-2711-2018-1-78-82
  41. Levin O.S., Chimagomedova A.Sh., Arefieva A.P. Anxiety in the elderly. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019; 119 (6): 113–8 (in Russ.). doi: 10.17116/jnevro2019119061113
  42. Müjgan Ö.E., Nergis A.S.Z., Solmaz T.A. et al. Somatization in Depression and Anxiety Disorders. J Psychiatry Neurol Sci. 2010; 23: 60-65. doi: 10.5350/DAJPN2010230109
  43. Mitscherlich A. The mechanism of bi-phasic defense in psychosomatic diseases. Int J Psychoanal. 1968; 49: 236–40.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2023
##common.cookie##